The researchers — led by Meghan Hufstader Gabriel, PhD, a health management and informatics researcher at University of Central Florida in Orlando — identified 3.1 million Medicare beneficiaries over the age of 66 with diabetes. They examined how using prescriptions transmitted to the pharmacy electronically impacted emergency department visits or hospitalizations for hypoglycemia or diabetes-related adverse drug events.
The researchers identified 21 adverse drug events per 1,000 beneficiaries who had 75 percent or more of their medications prescribed electronically. Those with lower electronic prescription levels had significantly higher numbers of adverse drug events. The researchers also saw an association between higher electronic prescription levels and lower risk of ED visits and inpatient hospitalizations.
More articles on health IT:
4 reasons MD Anderson put IBM Watson on hold
Humana taps Quartet for integrated mental health in New Orleans
Microsoft expands #MakeWhatsNext campaign to encourage women in STEM
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
